Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01175369 · ClinicalTrials.gov registry record · NA
School-based Asthma Therapy: Stage 2 Effectiveness Study
A NA study, sponsored by University of Rochester.
- Completed
- Registry status
- NA
- Development phase
- 530
- Enrollment target
NCT01175369 is a NA study that has completed, run by University of Rochester. The registered enrollment target is 530 participants.
The verdict
NCT01175369, a NA study, has completed, sponsored by University of Rochester.
- COMPLETED
- Registry status
- NA
- Development phase
- 530 participants
- Enrollment target
Study Summary
Asthma is the most common chronic illness of childhood, and hospitalization rates are increasing. In the US, impoverished children and children from minority ethnic and racial backgrounds suffer disproportionately from asthma. While National Heart, Lung, and Blood Institute (NHLBI) guidelines recommend daily preventive medications for all children with mild persistent to severe persistent asthma, studies indicate that many children in the US who should receive preventive medications are not receiving them. The overall goal of this project is to target an ethnically diverse population of inner-city schoolchildren with asthma and explore a school-based program to reduce asthma morbidity. We hypothesize that children receiving a comprehensive school-based intervention will experience less asthma-related morbidity compared to children receiving usual care. Our comprehensive school-based intervention consists of both administration of recommended preventive asthma medications in school (with dose adjustments according to NHLBI guidelines) and an environmental tobacco smoke (ETS) reduction program in the home for smoke-exposed children. Our secondary hypothesis is that, among the subgroup of smoke-exposed children, those who receive the school-based intervention with ETS reduction will experience less asthma morbidity than those who receive usual care.
Interventions
- BEHAVIORAL School-based Care
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 530 participants |
| Start Date | 2006-08 |
| Est. Completion | 2012-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01175369
The ClinicalTrials.gov registry entry for NCT01175369 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 530 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Rochester, which has 636 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which School-based Care is the first listed.
NCT01175369 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01175369 about?
NCT01175369 is a clinical study titled "School-based Asthma Therapy: Stage 2 Effectiveness Study". Asthma is the most common chronic illness of childhood, and hospitalization rates are increasing. In the US, impoverished children and children from minority ethnic and racial backgrounds suffer disproportionately from asthma. While National Heart, Lung, and Blood Institute (NHLBI) guidelines recomm...
What is the current status of trial NCT01175369?
This trial is currently completed. It is a NA study. The enrollment target is 530 participants. The study started on 2006-08. Estimated completion is 2012-01.
What interventions are being tested in trial NCT01175369?
The interventions under investigation include: School-based Care (BEHAVIORAL).
Who is sponsoring clinical trial NCT01175369?
This trial is sponsored by University of Rochester, which has 636 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.